{
  "ptid_time": "035_S_4784_2012-10-25",
  "img_path": "/data/qiuhui/data/adni/images/035_S_4784/2012-10-25/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 52,894 mm³, 43.1% above the reference mean. With a Z-score of 1.16 (87.8th percentile), this represents mild enlargement; hippocampal volume measures 3,914 mm³, 39.7% below the reference mean. With a Z-score of -3.18 (0.1th percentile), this represents profound atrophy; whole brain volume measures 1,048,900 mm³, 13.0% above the reference mean. With a Z-score of 1.56 (94.1th percentile), this represents moderate enlargement. ",
  "text_data": "Age is 81.6 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Musculoskeletal. MMSE: 26.0. MoCA: 22.0. Logical Memory: 1.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.03 SUVR (normal ); Amyloid beta: 1459.00 pg/mL (mild elevated); Total tau: 250.10 pg/mL (normal ); Phosphorylated tau: 21.35 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound hippocampal atrophy (Z-score -3.18, 0.1th percentile), which is strongly associated with Alzheimer's pathology, alongside mild ventricular enlargement. Cognitive scores (MMSE 26, MoCA 22) suggest mild cognitive impairment, and while Aβ is mildly elevated, tau markers are normal, indicating early-stage amyloid deposition without significant neurodegeneration.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology)  \n**Confidence:** **Medium** (due to conflicting biomarkers—hippocampal atrophy strongly suggests neurodegeneration, but tau levels are normal, and cognitive decline is mild).",
  "timestamp": "2025-07-26T05:58:36.045424"
}